{"slug":"n-acetyl-selank","seoKey":"nacetylselank","displayName":"N-Acetyl Selank Amidate","codes":["Ac-Selank-NH2","Ac-TKPRPGP-NH2"],"synonyms":["N-acetyl selank amidate","NA-Selank amidate","Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2","acetylated amidated Selank heptapeptide"],"legalClass":"research_chemical","identifiers":{},"approvals":[{"market":"US","status":"not_approved","date":"2026-09-23","note":"Not approved and not registered as a substance, not even as a bulk ingredient. openFDA drug/drugsfda and drug/label returned no match for any acetylated or amidated form on 2026-09-23; DailyMed lists no label. Of 9 bulk listings for Selank, NDC 73212-009 is named \"Selank Acetate\" but gives \"N-ACETYL SELANK\" as its active ingredient; none names the amidated form. The FDA list of bulk substances that may pose significant safety risks names Selank acetate, not the variant.","source":"https://api.fda.gov/drug/ndc.json?search=active_ingredients.name:selank"},{"market":"EU","status":"not_approved","date":"2026-09-23","note":"No centrally authorised medicine. The EMA data set of 2,746 human medicines contains \"selank\" 0 times on 2026-09-23 (control semaglutide: 10). No pharmacopoeia monograph.","source":"https://www.ema.europa.eu/en/documents/report/medicines-output-medicines_json-report_en.json"},{"market":"DE","status":"not_approved","date":"2026-09-23","note":"Neither a national nor an EU marketing authorisation, so not marketable as a medicinal product. Inferred from the EMA data set and the absence of any approval worldwide; no German database was queried directly. Not named in the annex to the Anti-Doping Act.","source":"https://www.ema.europa.eu/en/documents/report/medicines-output-medicines_json-report_en.json"},{"market":"UK","status":"not_approved","date":"2026-09-23","note":"No MHRA authorisation found. The MHRA database could not be queried automatically; the finding is inferred from the absence of any approval, application or clinical trial worldwide (as at 2026-09-23).","source":"https://products.mhra.gov.uk/"},{"market":"AU","status":"not_approved","date":"2026-09-23","note":"Not named in the Poisons Standard 2026; full-text search on 2026-09-23 returned 0 for \"selank\" (control BPC-157: 3). The ARTG was not queried directly. Absence of a listing is not a release: unregistered medicines may not be supplied in Australia.","source":"https://www.tga.gov.au/resources/artg"},{"market":"CA","status":"not_approved","date":"2026-09-23","note":"No marketing authorisation. Drug Product Database ingredient and brand searches for \"selank\" returned empty lists on 2026-09-23 (control semaglutide: 51 ingredient records).","source":"https://health-products.canada.ca/api/drug/activeingredient/?lang=en&type=json&ingredientname=selank"},{"market":"CH","status":"not_approved","date":"2026-09-23","note":"No marketing authorisation. The Swissmedic extended list of authorised medicines with active ingredients contains \"selank\" 0 times on 2026-09-23 (control semaglutid: 17).","source":"https://www.swissmedic.ch/swissmedic/de/home/services/listen_neu.html"}],"devStage":"preclinical","strongestEvidence":"none","wada":{"status":"prohibited","section":"S0","listYear":2026,"source":"https://www.wada-ama.org/en/prohibited-list"},"trials":[],"sameAs":[],"lastVerified":"2026-09-24","version":"1.0","published":true,"locale":"en","title":"N-Acetyl Selank Amidate: what the studies show, status and safety","summary":"N-Acetyl Selank Amidate is Selank, a peptide licensed as a medicine in Russia, with a small chemical cap added at each end. Searches of eight databases, each checked against a control search for Selank, found no test of this modified form in cells, animals or people. The only scientific paper found that names it lists it as a reference sample for a Belgian drug-testing method. No approval was found in any market checked, and no database record of its own. Everything claimed about its effects is borrowed from Selank, and it is banned in sport at all times.","updated":"2026-09-24","url":"https://mypep.app/peptides/n-acetyl-selank"}